r&d event 2023

On November 30 Lundbeck will be hosting our R&D Event 2023, taking place at the Science Gallery , Great Maze Pond, London.

At our R&D Event 2023 you will have the opportunity to gain insights from Lundbeck's CEO, Charl van Zyl, and EVP, Head of R&D, Johan Luthman, as well as members from the Lundbeck R&D organization. The team will be presenting the latest developments and the strategic roadmap for our transformative journey.

A live webcast from the Science Gallery will start at 12.30 GMT / 13.30 CET. To follow the webcast, please use the link below.

The presentation for the day will be available on the webcast page, as well as in our download center, on November 30.

Watch the webcast

This is Lundbeck

We are one of the only pharmaceutical companies in the world focusing exclusively on brain diseases, and we’re set apart by our specialization.

About Us

With more than 70 years of neuroscience expertise, Lundbeck has developed and commercialized some of the world's most widely prescribed therapies for brain diseases.

Our Science

LATEST NEWS

08 November, 2023 Corporate Release
Lundbeck's revenue in the first nine months of 2023 climbed to DKK 15 billion
14 September, 2023 Press Release
Lundbeck presents clinical advances in migraine prevention with positive trial results at international headache congress
07 September, 2023 Corporate Release
Lundbeck and Otsuka announce topline results from two phase III trials of brexpiprazole as combination therapy with sertraline for the treatment of Post-Traumatic Stress Disorder in adults

See All News

Come join us in making a difference to patients worldwide.

Job Opportunities

Explore the latest financial developments at Lundbeck.

Investors

a better life for people with brain diseases

At Lundbeck, we see patients as people and are committed to support the person and community behind the disease.

Our focus

Our Sustainability Strategy

Through our sustainability strategy, we mitigate business risks, reduce negative impacts, and address societal challenges where possible. We remain committed to UN Global Compact Principles, and contribute to seven of the 17 UN Sustainable Development Goals.

Partnering

The complexity of brain diseases requires a concerted effort. We are committed to develop new and better treatment options from innovations born in house or externally.

Mara Formentini on working at Lundbeck

Bringing Your Whole Self to Work and its Rewards

See All Stories

Lundbeck at a glance

100

countries where our products are sold

5,400

employees supporting our purpose

1915

year Lundbeck was founded

No Health Without Mental Health

We need every brain in the game